Needham Reiterates Buy on Collegium Pharmaceutical, Maintains $35 Price Target
Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $35 price target.
Needham Reiterates Buy on Personalis, Maintains $8 Price Target
Needham analyst Mike Matson reiterates Personalis (NASDAQ:PSNL) with a Buy and maintains $8 price target.
Telsey Advisory Group Reiterates Market Perform on Macy’s, Maintains $25 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Macy's (NYSE:M) with a Market Perform and maintains $25 price target.
Telsey Advisory Group Reiterates Outperform on Lowe’s Companies, Maintains $250 Price Target
Telsey Advisory Group analyst Joseph Feldman reiterates Lowe's Companies (NYSE:LOW) with a Outperform and maintains $250 price target.
EF Hutton Reiterates Buy on Tennant, Maintains $98 Price Target
EF Hutton analyst Tim Moore reiterates Tennant (NYSE:TNC) with a Buy and maintains $98 price target.
Canaccord Genuity Reiterates Buy on Block, Maintains $150 Price Target
Canaccord Genuity analyst Joseph Vafi reiterates Block (NYSE:SQ) with a Buy and maintains $150 price target.
Piper Sandler Reiterates Neutral on Riskified, Maintains $6 Price Target
Piper Sandler analyst Brent Bracelin reiterates Riskified (NYSE:RSKD) with a Neutral and maintains $6 price target.
Needham Reiterates Buy on Alnylam Pharmaceuticals, Maintains $240 Price Target
Needham analyst Joseph Stringer reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $240 price target.
Needham Reiterates Buy on Roku, Maintains $80 Price Target
Needham analyst Laura Martin reiterates Roku (NASDAQ:ROKU) with a Buy and maintains $80 price target.
Fiverr Analysts Boost Price Targets Expecting Cohorts And Macro To Stabilize In 2023
Needham analyst Bernie McTernan maintained Fiverr International Ltd (NYSE:FVRR) with a Buy and raised the price target from $40 to $50. The…